* Vinarol. The U fare and Drug Adm...

* Vinarol. The U fare and Drug Administration (FDA) has issued a MedWatch alert warning consumer not to purchase or expend Vinarol tablets. This product, which is being marketed as a dietary complement contains the unlabeled prescription mix with drugs ingredient sildenafil, which may put out serious health risks to an users. Vinarol is marketed in tablet form in blister packages of sum of two units and seven tablets and is labeled as distributed from Ultra Health Laboratories, Inc. or Bionate International, Inc. The outcome is being promoted for increasing desire, confidence, and sexual performance and is sold athwart the counter, as well as via the Internet.

The interaction between nitrates and sildenafil can be derived in profound and life-threatening lowering of vital fluid pressure. The use of nitrates in any form is an absolute contraindication in sildenafil users. The potential for this harvest to be taken by unknowing nitrate users is real, because erectile dysfunction is frequently a concurrent condition in patients with diabetes, hypertension, and hyperlipidemia, and in smoker and patients with ischemic heart disease.

Consumer who have used this result and have medical concerns are being advised to confer with their physician. Any adverse reactions experienced with the use of this outcome should be reported to the FDA MedWatch program on calling 800-FDA-1088.

COPYRIGHT 2003 American Academy of Family Physicians

COPYRIGHT 2003 Gale Group